Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral dosage form performance tests: new dissolution approaches.

Walter W Hauck1, Thomas Foster, Eric Sheinin

  • 1Biostatistics Section, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Pharmaceutical Research
|March 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution.

eLife·2026
Same author

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Therapeutic advances in neurological disorders·2026
Same author

A database of geomagnetic observatory monthly means: from historic to the satellite era.

Earth, planets, and space : EPS·2026
Same author

EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Proapoptotic Regulators.

Cancer research·2026
Same author

An ex vivo perfusion platform for the testing of cardiovascular interventional devices.

Nature reviews. Cardiology·2025
Same author

Structural basis for lipid binding by the blood protein vitronectin, a component of HDL.

bioRxiv : the preprint server for biology·2025

New methods for United States Pharmacopeia (USP) dissolution testing could improve risk assessment. These approaches aim to enhance the evaluation of bioavailability, bioequivalence, and drug safety and efficacy for oral dosage forms.

Area of Science:

  • Pharmaceutical Sciences
  • Regulatory Science
  • Drug Development

Background:

  • Performance tests, including dissolution, are crucial in United States Pharmacopeia (USP) monographs for oral dosage forms.
  • Dissolution acceptance criteria are established through private negotiations and inform judgments on bioavailability, bioequivalence, safety, and efficacy.

Purpose of the Study:

  • To discuss novel approaches for USP dissolution testing and acceptance criteria.
  • To propose methods that may enhance the assessment, management, and communication of risks in dissolution testing.

Main Methods:

  • Exploration of explicit hypothesis testing in dissolution assessment.
  • Consideration of parametric tolerance intervals for setting acceptance criteria.
  • Development of improved strategies for establishing dissolution acceptance criteria.

Related Experiment Videos

  • Proposal of a more flexible protocol for conformity assessment.

    • Main Results:

    • The current dissolution procedures are generally accepted but could be enhanced by new methodologies.
    • Proposed approaches offer potential improvements in risk assessment and communication for dissolution testing.

    Conclusions:

    • Adopting new approaches like hypothesis testing and improved criteria setting can refine dissolution testing.
    • These advancements may lead to better management of manufacturer and consumer risks related to drug performance.